Selected article for: "acute sars cov respiratory syndrome coronavirus and lung fibrosis"
Author: Ritter, Andreas; Kreis, Nina-Naomi; Louwen, Frank; Yuan, Juping
Title: Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics
  • Cord-id: umt46p9c
  • Document date: 2020_8_12
    • ID: umt46p9c
    Snippet: The coronavirus disease 2019 COVID-19 pandemic is rapidly spreading worldwide and is becoming a major public health crisis. Increasing evidence demonstrates a strong correlation between obesity and the COVID-19 disease. We have summarized recent studies and addressed the impact of obesity on COVID-19 in terms of hospitalization, severity, mortality, and patient outcome. We discuss the potential molecular mechanisms whereby obesity contributes to the pathogenesis of COVID-19. In addition to obesi
    Document: The coronavirus disease 2019 COVID-19 pandemic is rapidly spreading worldwide and is becoming a major public health crisis. Increasing evidence demonstrates a strong correlation between obesity and the COVID-19 disease. We have summarized recent studies and addressed the impact of obesity on COVID-19 in terms of hospitalization, severity, mortality, and patient outcome. We discuss the potential molecular mechanisms whereby obesity contributes to the pathogenesis of COVID-19. In addition to obesity-related deregulated immune response, chronic inflammation, endothelium imbalance, metabolic dysfunction, and its associated comorbidities, dysfunctional mesenchymal stem cells/adipose-derived mesenchymal stem cells may also play crucial roles in fueling systemic inflammation contributing to the cytokine storm and promoting pulmonary fibrosis causing lung functional failure, characteristic of severe COVID-19. Moreover, obesity may also compromise motile cilia on airway epithelial cells and impair functioning of the mucociliary escalators, reducing the clearance of severe acute respiratory syndrome coronavirus (SARS-CoV-2). Obese diseased adipose tissues overexpress the receptors and proteases for the SARS-CoV-2 entry, implicating its possible roles as virus reservoir and accelerator reinforcing violent systemic inflammation and immune response. Finally, anti-inflammatory cytokines like anti-interleukin 6 and administration of mesenchymal stromal/stem cells may serve as potential immune modulatory therapies for supportively combating COVID-19. Obesity is conversely related to the development of COVID-19 through numerous molecular mechanisms and individuals with obesity belong to the COVID-19-susceptible population requiring more protective measures.

    Search related documents:
    Co phrase search for related documents
    • aberrant systemic inflammatory response and acute ards respiratory distress syndrome: 1
    • aberrant systemic inflammatory response and acute sars cov respiratory syndrome coronavirus: 1, 2
    • abundant expression and acute ards respiratory distress syndrome: 1
    • abundant expression and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5
    • ace homology share and acute ards respiratory distress syndrome: 1
    • ace homology share and acute sars cov respiratory syndrome coronavirus: 1
    • activator kinase signal transducer and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4
    • activity regulate and acute ards respiratory distress syndrome: 1
    • activity regulate and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5
    • acute ards respiratory distress syndrome and adhesion molecule: 1, 2, 3, 4, 5, 6
    • acute phase and adhesion molecule: 1, 2
    • acute sars cov respiratory syndrome coronavirus and adhesion molecule: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute sars cov respiratory syndrome coronavirus and adipocyte dysfunction: 1